Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,679.02 -887.08 (-1.37%) CMC Crypto 200
1,324.28 -72.25 (-5.17%)
DexCom, Inc. (DXCM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:04PM EDT. Market open.
| Previous close | 138.01 |
| Open | 132.48 |
| Bid | 126.95 x 300 |
| Ask | 127.33 x 100 |
| Day's range | 126.68 - 138.80 |
| 52-week range | 74.75 - 142.00 |
| Volume | |
| Avg. volume | 3,087,224 |
| Market cap | 50.321B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 97.74 |
| EPS (TTM) | 1.30 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 151.32 |
ZacksDexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
GuruFocus.comDecoding DexCom Inc (DXCM): A Strategic SWOT Insight
Unveiling the Financial Fortitude and Market Dynamics of DexCom Inc (DXCM)
© 2024 Yahoo. All rights reserved.